Skip to content

Orthopaedic Products
Innovation & Development
Company Information
News & Updates
Get in Touch!

Orthopaedic
Products
Innovation
& Development
- CURRENT PROJECTS
  - Sr-HT-Gahnite
    - BLT Project
- PARTNER WITH US
Company
Information
- ABOUT ALLEGRA
- INVESTORS
News
& Updates
Get in
Touch!

Home » 20/02/13: Substantial Shareholder Notice Form 603

News & Updates

20/02/13: Substantial Shareholder Notice Form 603

20 February 20132 May 2018 •

Related

Visit Allegra at Booth #12, 2018 AOFAS Conference 17 – 19 August at Pullman Cairns International, QLD

Reconstruction for Acetabular Metastatic Disease

Improving Coating Techniques for Orthopaedic Implants

Recent Posts

Company Update – Innovation Division Shareholder Presentation August 2023
Meet Dr Roger Brighton, Surgeon Advisor
Improving Coating Techniques for Orthopaedic Implants
Exclusive Distribution of ChiroKlip®
Allegra confirms route to FDA approval following successful pilot animal study

Categories

Company News
Innovation & Development
Products

Keep up to date!

Receive newsletter updates weekly.

Privacy Policy | Sitemap
Corporate Governance
© Allegra

Customer Service

Phone: 1800 644 370
Fax: 1800 624 223
Email: sales@allegraorthopaedics.com

Corporate Office

Level 8, 18-20 Orion Road,
Lane Cove West, NSW 2066
Phone: +61 2 9119 9200
Fax: +61 2 9439 4441